Clobes Thomas A, Palmier Lauren A, Gagnon Matin, Klaiman Colby, Arellano Mya
California State University, Channel Islands 1 University Dr., Camarillo, CA 93012, USA.
The University of Health Sciences and Pharmacy in St. Louis 1 Pharmacy, Pl, St. Louis, MO 63110, USA.
PEC Innov. 2021 Dec 3;1:100009. doi: 10.1016/j.pecinn.2021.100009. eCollection 2022 Dec.
This research explores the impact of patient education on reducing historical and current stigma.
Participants were recruited through social media, parenting with community organizations, and snowball sampling. A pretest posttest method was utilized. Participants viewed five balanced educational videos about medicinal cannabis. Attitudes toward medical cannabis were measured with a modified version of the medical component of the Recreational and Medical Cannabis Attitudes Scale (RMCAS). In total, 111 participants completed all requirements of the study.
Results of a Wilcoxon Sign Rank Test demonstrated a significant increase in the modified medical component of the RMCAS (1.18, = 0.029).
Health education is an effective intervention to reduce stigma associated with medical cannabis. Future health policies must take a balanced, education-focused, and proactive stance in reducing barriers to care that exist due to the negative stigma associated with cannabis use.Innovation: Historically, patient education has focused on areas such as tobacco, automobile safety, vaccinations, obesity, and the like. This research applied patient education to the area of medical cannabis to improve attitudes toward it and improve patient access.
本研究探讨患者教育对减少历史和当前耻辱感的影响。
通过社交媒体、与社区组织合作育儿以及滚雪球抽样招募参与者。采用前测后测方法。参与者观看了五个关于药用大麻的平衡教育视频。使用娱乐性和药用大麻态度量表(RMCAS)的医学部分的修改版来测量对药用大麻的态度。共有111名参与者完成了研究的所有要求。
Wilcoxon符号秩检验结果显示,RMCAS修改后的医学部分有显著增加(1.18,P = 0.029)。
健康教育是减少与药用大麻相关耻辱感的有效干预措施。未来的卫生政策必须采取平衡、以教育为重点和积极主动的立场,以减少因与大麻使用相关的负面耻辱感而存在的医疗保健障碍。创新点:从历史上看,患者教育一直集中在烟草、汽车安全、疫苗接种、肥胖等领域。本研究将患者教育应用于药用大麻领域,以改善对其的态度并改善患者获得治疗的机会。